New pill takes aim at Cancer's DNA repair: first human trial begins
Disease control
Recruiting now
This early-stage trial tests an experimental oral drug called TRE-515 in adults with advanced solid tumors that no longer respond to standard treatments. The drug works by blocking a protein cancer cells need to make DNA, potentially slowing their growth. The main goals are to ch…
Phase: PHASE1 • Sponsor: Trethera • Aim: Disease control
Last updated Jun 26, 2026 16:33 UTC